DEPARTAMENT DE BIOLOGIA CEL·LULAR I ANATOMIA PATOLÒGICA FACULTAT DE MEDICINA

DEPARTAMENT DE BIOLOGIA CEL·LULAR I ANATOMIA PATOLÒGICA
FACULTAT DE MEDICINA
UNIVERSITAT DE BARCELONA
PROGRAMA DE DOCTORAT
BIOLOGIA I PATOLOGIA CEL·LULARS
Bienni 2002-2004
ANÀLISI DELS MECANISMES MOLECULARS IMPLICATS EN
EL DESENVOLUPAMENT I PROGRESSIÓ
DELS LIMFOMES DE CÈL·LULA B PETITA
Tesi presentada per Verònica Fernàndez Pascual
per optar al grau de Doctora en Biologia
Director de tesi: Dr. Elías Campo Güerri
Tutor: Dr. Carles Enrich Bastús
Barcelona 2008

Desenvolupament i progressió en limfomes de cèl·lula B petita Bibliografia
233
Un llegeix per fer-se preguntes (Franz Kafka)
BIBLIOGRAFIA

Desenvolupament i progressió en limfomes de cèl·lula B petita Bibliografia
234

Desenvolupament i progressió en limfomes de cèl·lula B petita Bibliografia
235
1 Muñoz A. Cáncer: genes y nuevas terapias. Editorial Hélice, 1997.
2 Evans LS, Hancock BW. Non-Hodgkin lymphoma. Lancet 2003; 362:139-146.
3 Gómez-Codina J. Linfomas B y T. Biología, clínica y tratamiento. Roche-Aula
Médica, 2002.
4 Chan JK. The new World Health Organization classification of lymphomas: the
past, the present and the future. Hematol Oncol 2001; 19:129-150.
5 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised
European-American classification of lymphoid neoplasms: a proposal from the
International Lymphoma Study Group. Blood 1994; 84:1361-1392.
6 Jox A, Wolf J, Diehl V. Hodgkin's disease biology: recent advances. Hematol
Oncol 1997; 15:165-171.
7 Kuppers R, Hansmann ML. The Hodgkin and Reed/Sternberg cell. Int J
Biochem Cell Biol 2005; 37:511-517.
8 Nakatsuka S, Aozasa K. Epidemiology and pathologic features of Hodgkin
lymphoma. Int J Hematol 2006; 83:391-397.
9 Nishikori M, Uchiyama T. Molecular pathogenesis of Hodgkin lymphoma. Int J
Hematol 2006; 83:398-403.
10 Gamberi B, Gaidano G, Parsa N, Carbone A, Roncella S, Knowles DM et al.
Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood 1997;
89:975-979.
11 Macintyre E, Willerford D, Morris SW. Non-Hodgkin's Lymphoma: Molecular
Features of B Cell Lymphoma. Hematology (Am Soc Hematol Educ Program )
2000;180-204.
12 Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma--a
review. Acta Oncol 2006; 45:258-271.
13 Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene
2004; 23:6524-6534.
14 Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations
from the B-cell receptor. Blood 2004; 103:4389-4395.
15 Messmer BT, Messmer D, Allen SL, Kolitz JE, Kudalkar P, Cesar D et al. In vivo
measurements document the dynamic cellular kinetics of chronic lymphocytic
leukemia B cells. J Clin Invest 2005; 115:755-764.
16 Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ et al.
Inherited predisposition to CLL is detectable as subclinical monoclonal B-
lymphocyte expansion. Blood 2002; 100:2289-2290.
17 Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative
tumors in families of patients with chronic lymphocytic leukemia: results from
the Swedish Family-Cancer Database. Blood 2004; 104:1850-1854.

Desenvolupament i progressió en limfomes de cèl·lula B petita Bibliografia
236
18 Herishanu Y, Polliack A. Chronic lymphocytic leukemia: a review of some new
aspects of the biology, factors influencing prognosis and therapeutic options.
Transfus Apher Sci 2005; 32:85-97.
19 Rudd MF, Sellick GS, Webb EL, Catovsky D, Houlston RS. Variants in the
ATM-BRCA2-CHEK2 axis predispose to chronic lymphocytic leukaemia. Blood
2006; 108:638-644.
20 Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med
2005; 352:804-815.
21 Kokhaei P, Palma M, Mellstedt H, Choudhury A. Biology and treatment of
chronic lymphocytic leukemia. Ann Oncol 2005; 16 Suppl 2:ii113-ii123.
22 Dunphy CH. Gene expression profiling data in lymphoma and leukemia: review
of the literature and extrapolation of pertinent clinical applications. Arch Pathol
Lab Med 2006; 130:483-520.
23 Dyer MJ, Oscier DG. The configuration of the immunoglobulin genes in B cell
chronic lymphocytic leukemia. Leukemia 2002; 16:973-984.
24 DamleRN,WasilT,FaisF,GhiottoF,ValettoA,AllenSLetal.IgVgene
mutation status and CD38 expression as novel prognostic indicators in chronic
lymphocytic leukemia. Blood 1999; 94:1840-1847.
25 Capello D, Guarini A, Berra E, Mauro FR, Rossi D, Ghia E et al. Evidence of
biased immunoglobulin variable gene usage in highly stable B-cell chronic
lymphocytic leukemia. Leukemia 2004; 18:1941-1947.
26 Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H)
genes are associated with a more aggressive form of chronic lymphocytic
leukemia. Blood 1999; 94:1848-1854.
27 Mauerer K, Zahrieh D, Gorgun G, Li A, Zhou J, Ansen S et al. Immunoglobulin
gene segment usage, location and immunogenicity in mutated and unmutated
chronic lymphocytic leukaemia. Br J Haematol 2005; 129:499-510.
28 Tobin G, Thunberg U, Karlsson K, Murray F, Laurell A, Willander K et al.
Subsets with restricted immunoglobulin gene rearrangement features indicate a
role for antigen selection in the development of chronic lymphocytic leukemia.
Blood 2004; 104:2879-2885.
29 Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al.
Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J
Med 2000; 343:1910-1916.
30 Sindelarova L, Michalova K, Zemanova Z, Ransdorfova S, Brezinova J, Pekova
S et al. Incidence of chromosomal anomalies detected with FISH and their
clinical correlations in B-chronic lymphocytic leukemia. Cancer Genet
Cytogenet 2005; 160:27-34.
31 Stilgenbauer S, Lichter P, Dohner H. Genetic features of B-cell chronic
lymphocytic leukemia. Rev Clin Exp Hematol 2000; 4:48-72.